CY1106350T1 - Εμβολιο φυματιωσης - Google Patents
Εμβολιο φυματιωσηςInfo
- Publication number
- CY1106350T1 CY1106350T1 CY20071100297T CY071100297T CY1106350T1 CY 1106350 T1 CY1106350 T1 CY 1106350T1 CY 20071100297 T CY20071100297 T CY 20071100297T CY 071100297 T CY071100297 T CY 071100297T CY 1106350 T1 CY1106350 T1 CY 1106350T1
- Authority
- CY
- Cyprus
- Prior art keywords
- nucleic acid
- acid molecules
- tuberculosis vaccine
- relates
- present
- Prior art date
Links
- 229960002109 tuberculosis vaccine Drugs 0.000 title 1
- 102000039446 nucleic acids Human genes 0.000 abstract 4
- 108020004707 nucleic acids Proteins 0.000 abstract 4
- 150000007523 nucleic acids Chemical class 0.000 abstract 4
- 108010008038 Synthetic Vaccines Proteins 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 229940124551 recombinant vaccine Drugs 0.000 abstract 1
- 201000008827 tuberculosis Diseases 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97114614A EP0902086A1 (en) | 1997-08-22 | 1997-08-22 | Tuberculosis vaccine |
| PCT/EP1998/005109 WO1999010496A1 (en) | 1997-08-22 | 1998-08-12 | Tuberculosis vaccine |
| EP98947427A EP1007686B1 (en) | 1997-08-22 | 1998-08-12 | Tuberculosis vaccine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1106350T1 true CY1106350T1 (el) | 2011-10-12 |
Family
ID=8227261
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20071100297T CY1106350T1 (el) | 1997-08-22 | 2007-03-01 | Εμβολιο φυματιωσης |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6673353B1 (enExample) |
| EP (2) | EP0902086A1 (enExample) |
| JP (1) | JP4255209B2 (enExample) |
| AT (1) | ATE347599T1 (enExample) |
| AU (1) | AU9435098A (enExample) |
| CA (1) | CA2301879C (enExample) |
| CY (1) | CY1106350T1 (enExample) |
| DE (1) | DE69836588T2 (enExample) |
| DK (1) | DK1007686T3 (enExample) |
| ES (1) | ES2274580T3 (enExample) |
| PT (1) | PT1007686E (enExample) |
| SI (1) | SI1007686T1 (enExample) |
| WO (1) | WO1999010496A1 (enExample) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8956621B2 (en) | 1994-11-08 | 2015-02-17 | The Trustees Of The University Of Pennsylvania | Compositions and methods for treatment of cervical dysplasia |
| US8114414B2 (en) | 1994-11-08 | 2012-02-14 | The Trustees Of The University Of Pennsylvania | Compositions and methods for treatment of cervical cancer |
| US8791237B2 (en) | 1994-11-08 | 2014-07-29 | The Trustees Of The University Of Pennsylvania | Compositions and methods for treatment of non-hodgkins lymphoma |
| US7794729B2 (en) | 1994-11-08 | 2010-09-14 | The Trustees Of The University Of Pennsylvania | Methods and compositions for immunotherapy of cancer |
| US7662396B2 (en) | 2001-03-26 | 2010-02-16 | The Trustees Of The University Of Pennsylvania | Compositions and methods for enhancing the immunogenicity of antigens |
| US6051237A (en) | 1994-11-08 | 2000-04-18 | The Trustees Of The University Of Pennsylvania | Specific immunotherapy of cancer using a live recombinant bacterial vaccine vector |
| US7820180B2 (en) * | 2004-09-24 | 2010-10-26 | The Trustees Of The University Of Pennsylvania | Listeria-based and LLO-based vaccines |
| CA2348475A1 (en) * | 1998-11-04 | 2000-05-11 | Isis Innovation Limited | Tuberculosis diagnostic test |
| GB0006693D0 (en) * | 2000-03-20 | 2000-05-10 | Glaxo Group Ltd | Vaccine |
| US9012141B2 (en) | 2000-03-27 | 2015-04-21 | Advaxis, Inc. | Compositions and methods comprising KLK3 of FOLH1 antigen |
| IL151942A0 (en) | 2000-03-29 | 2003-04-10 | Univ Pennsylvania | Compositions and methods for enhancing immunogenicity of antigens |
| US6855320B2 (en) | 2000-03-29 | 2005-02-15 | The Trustees Of The University Of Pennsylvania | Fusion of non-hemolytic, truncated form of listeriolysin O to antigens to enhance immunogenicity |
| US7700344B2 (en) | 2001-03-26 | 2010-04-20 | The Trustees Of The University Of Pennsylvania | Compositions and methods for enhancing the immunogenicity of antigens |
| US8771702B2 (en) | 2001-03-26 | 2014-07-08 | The Trustees Of The University Of Pennsylvania | Non-hemolytic LLO fusion proteins and methods of utilizing same |
| KR101192652B1 (ko) * | 2003-02-06 | 2012-10-19 | 앤저 테라퓨틱스 인코퍼레이티드 | 비포식 세포로의 침투가 약화된 리스테리아, 리스테리아를 포함하는 백신, 및 그것의 사용방법 |
| MXPA05011360A (es) | 2003-04-23 | 2005-11-28 | Max Planck Gesellschaft | Vacuna contra la tuberculosis con eficiencia mejorada. |
| EP1649869A1 (en) * | 2004-10-21 | 2006-04-26 | Vakzine Projekt Management GmbH | Combination of a recombinant mycobacterium and a biologically active agent as a vaccine |
| AP2007004033A0 (en) * | 2004-12-01 | 2007-06-30 | Aeras Global Tb Baccine Founda | Recombinant bcg strains with enhanced ability to escape the endosome |
| US8241636B2 (en) | 2006-08-15 | 2012-08-14 | The Trustees Of The University Of Pennsylvania | Compositions comprising HMW-MAA and fragments thereof, and methods of use thereof |
| US8268326B2 (en) | 2006-08-15 | 2012-09-18 | The Trustees Of The University Of Pennsylvania | Compositions comprising HMW-MAA and fragments thereof, and methods of use thereof |
| US9017660B2 (en) | 2009-11-11 | 2015-04-28 | Advaxis, Inc. | Compositions and methods for prevention of escape mutation in the treatment of Her2/neu over-expressing tumors |
| US9650639B2 (en) | 2008-05-19 | 2017-05-16 | Advaxis, Inc. | Dual delivery system for heterologous antigens |
| WO2009143167A2 (en) | 2008-05-19 | 2009-11-26 | Advaxis | Dual delivery system for heterologous antigens |
| EP3269799A1 (en) | 2009-03-04 | 2018-01-17 | The Trustees of the University of Pennsylvania | Compositions comprising angiogenic factors and uses thereof |
| US10016617B2 (en) | 2009-11-11 | 2018-07-10 | The Trustees Of The University Of Pennsylvania | Combination immuno therapy and radiotherapy for the treatment of Her-2-positive cancers |
| EP3360569B1 (en) * | 2010-09-20 | 2020-03-18 | Vakzine Projekt Management GmbH | Recombinant mycobacterium as vaccine for use in humans |
| JP5981436B2 (ja) | 2010-10-01 | 2016-08-31 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | 寄生的に感染している対象におけるワクチン不応答性を反転させるためのリステリアワクチンベクターの使用 |
| EP2654783B1 (en) | 2010-12-21 | 2016-10-05 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Recombinant mycobacterium as a vaccine |
| SI2656070T1 (sl) * | 2010-12-21 | 2016-05-31 | Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V. | Ugotavljanje učinkovitosti živega rekombinantnega antimikobakterijskega cepljenja |
| WO2012125551A1 (en) | 2011-03-11 | 2012-09-20 | Advaxis | Listeria-based adjuvants |
| BR102012003790A2 (pt) | 2012-02-17 | 2014-04-22 | Fundacao Butantan | Cepa de mycobacterium recombinante, composição imunogênica e uso |
| HK1205944A1 (en) | 2012-03-12 | 2015-12-31 | 阿德瓦希斯公司 | Suppressor cell function inhibition following listeria vaccine treatment |
| AU2013243922A1 (en) * | 2012-04-02 | 2014-10-02 | The Arizona Board Of Regents For And On Behalf Of Arizona State University | Recombinant bacterium for induction of cellular immune response |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5504005A (en) * | 1987-03-02 | 1996-04-02 | Albert Einstein College Of Medicine Of Yeshiva University | Recombinant mycobacterial vaccine |
-
1997
- 1997-08-22 EP EP97114614A patent/EP0902086A1/en not_active Withdrawn
-
1998
- 1998-08-12 SI SI9830871T patent/SI1007686T1/sl unknown
- 1998-08-12 JP JP2000507804A patent/JP4255209B2/ja not_active Expired - Lifetime
- 1998-08-12 DK DK98947427T patent/DK1007686T3/da active
- 1998-08-12 AU AU94350/98A patent/AU9435098A/en not_active Abandoned
- 1998-08-12 CA CA2301879A patent/CA2301879C/en not_active Expired - Lifetime
- 1998-08-12 WO PCT/EP1998/005109 patent/WO1999010496A1/en not_active Ceased
- 1998-08-12 PT PT98947427T patent/PT1007686E/pt unknown
- 1998-08-12 AT AT98947427T patent/ATE347599T1/de active
- 1998-08-12 US US09/485,717 patent/US6673353B1/en not_active Expired - Lifetime
- 1998-08-12 ES ES98947427T patent/ES2274580T3/es not_active Expired - Lifetime
- 1998-08-12 DE DE69836588T patent/DE69836588T2/de not_active Expired - Lifetime
- 1998-08-12 EP EP98947427A patent/EP1007686B1/en not_active Expired - Lifetime
-
2007
- 2007-03-01 CY CY20071100297T patent/CY1106350T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SI1007686T1 (sl) | 2007-04-30 |
| US6673353B1 (en) | 2004-01-06 |
| ATE347599T1 (de) | 2006-12-15 |
| AU9435098A (en) | 1999-03-16 |
| DE69836588D1 (de) | 2007-01-18 |
| PT1007686E (pt) | 2007-03-30 |
| EP1007686B1 (en) | 2006-12-06 |
| EP1007686A1 (en) | 2000-06-14 |
| CA2301879C (en) | 2014-02-04 |
| JP2001514000A (ja) | 2001-09-11 |
| CA2301879A1 (en) | 1999-03-04 |
| EP0902086A1 (en) | 1999-03-17 |
| DE69836588T2 (de) | 2007-04-05 |
| DK1007686T3 (da) | 2007-04-10 |
| JP4255209B2 (ja) | 2009-04-15 |
| ES2274580T3 (es) | 2007-05-16 |
| WO1999010496A1 (en) | 1999-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1106350T1 (el) | Εμβολιο φυματιωσης | |
| CY1110793T1 (el) | Εμβολιο φυματιωσης με βελτιωμενη αποτελεσματικοτητα | |
| BR9906927A (pt) | Proteìnas de neisseria meningitidis | |
| DE60142922D1 (de) | Für antigene polypeptide des hiv type c kodierende nukleinsäuren, entsprechende polypeptide und verwendungen davon | |
| DE60235039D1 (de) | Egvii-endoglucanase und dafür codierende nukleinsäuren | |
| ATE184052T1 (de) | Gdf-1 und uog1 proteine | |
| NZ335485A (en) | Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof | |
| DE69518751D1 (de) | Gereinigte scytalidium lacassen und nukleinsäuren dafür kodierend | |
| DK1025211T3 (da) | Hyaluronansyntasegen og anvendelser deraf | |
| ATE312920T1 (de) | Dna immunisierung gegen chlamydia infektion | |
| CY1117746T1 (el) | Αντιγονα αιμοφιλου της γριπης και αντιστοιχα θραυσματα dna | |
| DE69230671D1 (de) | Impfstoffe gegen actinobacillus pleuropneumonie | |
| DK0892054T3 (da) | Clostridium perfringens-vaccine | |
| NO983946D0 (no) | Parapoksyviruser inneholdende fremmed DNA, fremstilling og anvendelse derav i vaksiner | |
| DK0914437T3 (da) | Identificering og kloning af et mykobakterieantigen svarende til et heparinbindende hæmagglutinin | |
| BR0011469A (pt) | Gm-csf equina | |
| ATE234628T1 (de) | Therapeutische anwendungen von antigenen oder epitopen assoziert mit unvollständiger zellulärer peptidprozesierung , z.b.: exprimiert in rma-s zellen transfiziert mit b7-1 gen | |
| NO960749D0 (no) | Rekombinante Cladosporium herbarum allergener | |
| DK0691404T3 (da) | Vaccine til immunisering mod TBE-virusinfektioner samt en fremgangsmåde til fremstilling deraf | |
| BR0013574A (pt) | Antìgeno vacina de moraxella | |
| EP1561817A3 (en) | Modified CEA and uses thereof | |
| BR9810046A (pt) | Sequência de nucleotìdeos, vetor de expressão, célula hospedeira, proteìna de esperma de mamìfero, proteìna de esperma recombinante, proteìna 4, 1 e/ou 6,7 de esperma, composição farmacêutica, e, vacina contraceptiva |